The nexus between PFAS and poverty in
LMICs
PFAS and Cancer Risk: PFAS, a group of man-made chemicals utilized globally since the 1940s,
have been linked to an increased risk of various cancers. High levels of PFOS,
a type of PFAS, are associated with liver metabolic changes, suggesting a
heightened cancer risk due to disrupted fat metabolism. Similarly, elevated
blood levels of PFNA, another PFAS compound, have been correlated with an
increased risk of kidney cancer, particularly among African American
individuals.
The Multiplicative Effects of PFAS and Cancer on Poverty in LMICs: The
confluence of PFAS exposure, cancer prevalence, and poverty can significantly
exacerbate socioeconomic challenges in LMICs.
- PFAS Exposure and Health Inequities:
- PFAS are persistent environmental
pollutants that accumulate in the human body and the environment, posing
long-term health risks.
- In LMICs, insufficient regulation and
oversight can result in elevated PFAS levels in the environment,
increasing exposure risk for the populace.
- Cancer Burden and Economic Strain:
- Cancer is a leading cause of mortality
globally, with a disproportionate number of cases in LMICs.
- The economic burden of cancer in these
countries is intensified by the high costs of treatment and limited
healthcare access.
- Multiplicative Effect on Poverty:
- The combined impact of PFAS exposure
and cancer can precipitate a poverty cycle. Illness can diminish a
family’s earning capacity, while treatment costs can exhaust savings and
lead to indebtedness.
- This cycle is often worsened in LMICs
where social safety nets are typically weak or absent, leaving families
without support during health crises.
- Impact on
Sustainable Development:
- The
multiplicative effect of PFAS and cancer on poverty also impedes
sustainable development in LMICs.
- Anti-poverty
efforts are compromised by the escalated healthcare costs and diminished
productivity stemming from these health issues.
- Need for Global Action:
- Tackling the multiplicative effect of
PFAS and cancer on poverty necessitates international collaboration.
- Initiatives to curtail PFAS usage,
enhance cancer care, and bolster economic support for impacted
populations are crucial to breaking the poverty cycle in LMICs.
The
interplay between PFAS, cancer, and poverty presents a complex challenge for
LMICs, highlighting the need for comprehensive policies and global support to
mitigate these risks and foster equitable, sustainable development.
Economic Implications of PFAS in LMICs: PFAS present significant
economic challenges for LMICs, impacting healthcare, productivity,
environmental remediation, trade, and industry.
- Healthcare Costs
and Treatment Expenses:
- PFAS-related
health conditions, including cancer and liver damage, can overburden LMIC
healthcare budgets.
- Families
facing PFAS-related illnesses often incur substantial out-of-pocket
expenses, leading to financial instability and potential impoverishment.
- Lost Productivity
and Workforce Impact:
- Health
issues linked to PFAS can result in lost productivity due to illness,
disability, or premature death.
- The
workforce in LMICs may suffer reduced productivity, affecting economic
growth and development.
- Environmental Remediation Costs:
- Cleaning up PFAS-contaminated sites is
costly and complex due to the chemicals’ environmental persistence.
- LMICs frequently lack the resources and
expertise for effective remediation, placing the economic burden on
governments and communities.
- Trade and Industry Impact:
- Industries in some LMICs that rely on
PFAS-containing products may face disruptions if PFAS use is restricted,
impacting employment and economic stability.
- Long-Term Costs and Externalization:
- The true costs of PFAS are long-term,
poorly understood, and often externalized onto individuals, communities,
and governments.
- While corporations benefit from PFAS
production, the public bears the costs, frequently without their
knowledge.
Addressing
the economic implications of PFAS in LMICs requires a holistic approach,
including improved regulation, healthcare infrastructure, and sustainable
alternatives. Proactive measures can mitigate long-term consequences and
safeguard both health and economies.
PFAS, Poverty, and Cancer in LMICs: In LMICs, the intersection
of PFAS exposure and poverty leads to a dire situation. Industrialization and
globalization, which have popularized PFAS use, also contribute to lifestyle
and dietary changes that increase cancer cases. However, LMICs are often
ill-equipped to manage this rise due to inadequate infrastructure and training,
resulting in high morbidity and mortality rates from potentially preventable or
more effectively treatable cancers with better resources. Furthermore, the
socio-economic challenges faced by cancer patients in LMICs can lead to
impoverishment due to catastrophic healthcare costs and lost productivity,
trapping families in a cycle of poverty and ill health.
1.
Targol
Teymourian, Termeh Teymoorian, Elaheh Kowsari, & Seeram Ramakrishna.
(2021). A review of emerging
PFAS contaminants: sources, fate, health risks, and a comprehensive assortment
of recent sorbents for PFAS treatment by evaluating their mechanismResearch
on Chemical Intermediates, 47, 4879–4914.
2.
Hubertus
Brunn, Gottfried Arnold, Wolfgang Körner, Gerd Rippen, Klaus Günter
Steinhäuser, & Ingo Valentin. (2023). PFAS: forever chemicals—persistent,
bioaccumulative and mobile. Reviewing the status and
the need for their phase out and remediation of contaminated sitesEnvironmental
Sciences Europe, 35, Article number: 20.
3.
Centers for
Disease Control and Prevention (CDC). (n.d.). PFAS: an overview of the
science and guidance for clinicians on per- and polyfluoroalkyl substances.
4.
Compilation
of research on PFAS in the environment. (2021)Phys.org.
5.
Death C,
Bell C, Champness D, Milne C, Reichman S, Hagen T. (n.d.). PFAS on atmospheric
aerosol particles: a reviewEurope PMC.
Comments
Post a Comment